Efficacy and Safety of RAD001 as Second Line Therapy in Biliary Tract Cancer (BTC) Patients (pts) – a Phase II I.T.M.O. (Italian Trials in Medical Oncology) Group Study

R. Buzzoni; S. Pusceddu; P. Biondani; M. Cantore; E. Aitini; A. Bertolini; ALABISO Oscar; L. Isa; G. Pinotti; E. Bajetta

doi:10.1016/S0959-8049(11)71937-2

Efficacy and Safety of RAD001 as Second Line Therapy in Biliary Tract Cancer (BTC) Patients (pts) – a Phase II I.T.M.O. (Italian Trials in Medical Oncology) Group Study

R. Buzzoni
, S. Pusceddu
, P. Biondani
, M. Cantore
, E. Aitini
, A. Bertolini
, ALABISO Oscar
, L. Isa
, G. Pinotti
, E. Bajetta

Risultato della ricerca: Contributo alla conferenza › Poster

Lingua originale	Inglese
Pagine	S479-S480
Numero di pagine	2
DOI	https://doi.org/10.1016/S0959-8049(11)71937-2
Stato di pubblicazione	Pubblicato - 1 gen 2011
Pubblicato esternamente	Sì
Evento	European Multidisciplinary Cancer Congress - Stockholm, Sweden Durata: 1 gen 2011 → …

???event.eventtypes.event.conference???

???event.eventtypes.event.conference???	European Multidisciplinary Cancer Congress
Città	Stockholm, Sweden
Periodo	1/01/11 → …

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Accesso al documento

10.1016/S0959-8049(11)71937-2

Altri file e collegamenti

handle

Cita questo

Buzzoni, R., Pusceddu, S., Biondani, P., Cantore, M., Aitini, E., Bertolini, A., Oscar, ALABISO., Isa, L., Pinotti, G., & Bajetta, E. (2011). Efficacy and Safety of RAD001 as Second Line Therapy in Biliary Tract Cancer (BTC) Patients (pts) – a Phase II I.T.M.O. (Italian Trials in Medical Oncology) Group Study. S479-S480. Sessione di poster presentata al European Multidisciplinary Cancer Congress, Stockholm, Sweden. https://doi.org/10.1016/S0959-8049(11)71937-2

@conference{b5c2b17604d34f3ea7e15a3e474d412d,

title = "Efficacy and Safety of RAD001 as Second Line Therapy in Biliary Tract Cancer (BTC) Patients (pts) – a Phase II I.T.M.O. (Italian Trials in Medical Oncology) Group Study",

author = "R. Buzzoni and S. Pusceddu and P. Biondani and M. Cantore and E. Aitini and A. Bertolini and ALABISO Oscar and L. Isa and G. Pinotti and E. Bajetta",

year = "2011",

month = jan,

day = "1",

doi = "10.1016/S0959-8049(11)71937-2",

language = "English",

pages = "S479--S480",

note = "European Multidisciplinary Cancer Congress ; Conference date: 01-01-2011",

}

Buzzoni, R, Pusceddu, S, Biondani, P, Cantore, M, Aitini, E, Bertolini, A, Oscar, ALABISO, Isa, L, Pinotti, G & Bajetta, E 2011, 'Efficacy and Safety of RAD001 as Second Line Therapy in Biliary Tract Cancer (BTC) Patients (pts) – a Phase II I.T.M.O. (Italian Trials in Medical Oncology) Group Study', European Multidisciplinary Cancer Congress, Stockholm, Sweden, 1/01/11 pagg. S479-S480. https://doi.org/10.1016/S0959-8049(11)71937-2

Efficacy and Safety of RAD001 as Second Line Therapy in Biliary Tract Cancer (BTC) Patients (pts) – a Phase II I.T.M.O. (Italian Trials in Medical Oncology) Group Study. / Buzzoni, R.; Pusceddu, S.; Biondani, P. et al.
2011. S479-S480 Sessione di poster presentata al European Multidisciplinary Cancer Congress, Stockholm, Sweden.

Risultato della ricerca: Contributo alla conferenza › Poster

TY - CONF

T1 - Efficacy and Safety of RAD001 as Second Line Therapy in Biliary Tract Cancer (BTC) Patients (pts) – a Phase II I.T.M.O. (Italian Trials in Medical Oncology) Group Study

AU - Buzzoni, R.

AU - Pusceddu, S.

AU - Biondani, P.

AU - Cantore, M.

AU - Aitini, E.

AU - Bertolini, A.

AU - Oscar, ALABISO

AU - Isa, L.

AU - Pinotti, G.

AU - Bajetta, E.

PY - 2011/1/1

Y1 - 2011/1/1

UR - https://iris.uniupo.it/handle/11579/58371

U2 - 10.1016/S0959-8049(11)71937-2

DO - 10.1016/S0959-8049(11)71937-2

M3 - Poster

SP - S479-S480

T2 - European Multidisciplinary Cancer Congress

Y2 - 1 January 2011

ER -

Buzzoni R, Pusceddu S, Biondani P, Cantore M, Aitini E, Bertolini A et al.. Efficacy and Safety of RAD001 as Second Line Therapy in Biliary Tract Cancer (BTC) Patients (pts) – a Phase II I.T.M.O. (Italian Trials in Medical Oncology) Group Study. 2011. Sessione di poster presentata al European Multidisciplinary Cancer Congress, Stockholm, Sweden. doi: 10.1016/S0959-8049(11)71937-2